Pharmaceutical Business review

ProMetic names new CFO

Over the last two years Mr Prichard served as CFO of ProMetic BioSciences, its UK division and in addition assumed the role of vice president of corporate development at ProMetic in October 2007.

The company has also announced that Ronald Guttmann will be retiring from its board of directors, effective immediately, citing personal business activities.

Pierre Laurin, president and CEO of ProMetic group, said: “Bruce has a clear track record of streamlining cross-border finance functions. This coupled with his experience in structuring financial transactions from public and private sources will ensure that ProMetic is well placed to achieve its goals for continued growth.”